TWIN CAPITAL MANAGEMENT INC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1059187 MCMURRAY, PA

Position in VRTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$911,996

+$72,948 QoQ

Shares Held

1,836

-2.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#882

of 1,735 holders

Holding Since

Sep 2021

18 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

TWIN CAPITAL MANAGEMENT INC holds $3,591,759 across 4 Biotechnology names. VRTX ranks #2 (25.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	9,198	$1,042,685
2	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,836	$911,996
3	HALO	Halozyme Therapeutics, Inc.	11,348	$888,207
4	REGN	Regeneron Pharmaceuticals, Inc.	1,201	$748,871

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$911,996	1,836	-2.3%	Shares	Sole	2026-08-06
2026-03-31	$839,048	1,879	-2.1%	Shares	Sole	2026-05-05
2025-12-31	$869,997	1,919	+0.7%	Shares	Sole	2026-02-06
2025-09-30	$746,074	1,905	-35.0%	Shares	Sole	2025-11-05
2024-12-31	$1,181,119	2,933	-49.1%	Shares	Sole	2025-02-13
2024-09-30	$2,678,395	5,759	-2.3%	Shares	Sole	2024-11-12
2024-06-30	$2,762,635	5,894	+0.5%	Shares	Sole	2024-08-14
2024-03-31	$2,451,210	5,864	-5.3%	Shares	Sole	2024-05-13
2023-12-31	$2,519,462	6,192	-2.5%	Shares	Sole	2024-01-31
2023-09-30	$2,209,539	6,354	-6.5%	Shares	Sole	2023-11-13
2023-06-30	$2,391,228	6,795	-3.7%	Shares	Sole	2023-08-07
2023-03-31	$2,223,448	7,057	-33.6%	Shares	Sole	2023-05-08
2022-12-31	$3,067,132	10,621	-0.3%	Shares	Sole	2023-01-31
2022-09-30	$3,084,759	10,654	-0.7%	Shares	Sole	2022-10-21
2022-06-30	$3,021,915	10,724	+65.3%	Shares	Sole	2022-08-02
2022-03-31	$1,693,434	6,489	+1.3%	Shares	Sole	2022-05-06
2021-12-31	$1,406,318	6,404	+23.7%	Shares	Sole	2022-02-07
2021-09-30	$938,693	5,175	—	Shares	Sole	2021-10-29
No filing history on record for this holder in this stock.